← Leaderboards
Angela Demichele
University Of Pennsylvania
$6,304,623
Attributed
$7,923,353
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,923,353 · 9
By mechanism
R01$4,669,627 · 2
P01$1,843,510 · 2
P30$905,564 · 4
K23$504,652 · 1
Top collaborators
- Lewis A Chodosh5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen G Emerson$28,932,839
- Carl H. June$35,377,952
- James L Riley$56,591,102
- Peter J O'Dwyer$138,294,037
- Mitchell D Schnall$128,628,301
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationMalignant Breast NeoplasmBiological MarkersClinical TrialsProgramsMalignant NeoplasmsTreatment ResponseNovel TherapeuticsResponse BiomarkerClinical ResearchMolecularRecurrenceTumorDetectionLaboratoriesResponseWomanBreastGeneticBiologyCancer Center Support GrantCancer CenterDirect CostsCancer Biology
Grant awards (40)
Project 1: Imaging, pathology, and molecular biomarkers to Optimize Treatment Switching within a SMART adaptive Framework$300,575
P01 · FY2025 · CA · contact PI
Breast Cancer Program$81,489
P30 · FY2025 · CA · contact PI
Project 1: Imaging, pathology, and molecular biomarkers to Optimize Treatment Switching within a SMART adaptive Framework$298,095
P01 · FY2024 · CA · contact PI
Breast Cancer Program$83,260
P30 · FY2024 · CA · contact PI
Project 1: Imaging, pathology, and molecular biomarkers to Optimize Treatment Switching within a SMART adaptive Framework$343,192
P01 · FY2023 · CA · contact PI
Breast Cancer Program$83,258
P30 · FY2023 · CA · contact PI
Breast Cancer Program$84,880
P30 · FY2022 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$634,332
R01 · FY2021 · CA
Project 01 - Sequential Multiple Assignment Randomization using imaging and molecular biomarkers in I-SPY 2 non-responders$189,547
P01 · FY2021 · CA · contact PI
Breast Cancer Program$83,107
P30 · FY2021 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$643,007
R01 · FY2020 · CA
Project 01 - Sequential Multiple Assignment Randomization using imaging and molecular biomarkers in I-SPY 2 non-responders$166,076
P01 · FY2020 · CA · contact PI
Breast Cancer Research Program$79,988
P30 · FY2020 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$632,007
R01 · FY2019 · CA
Project 01 - Sequential Multiple Assignment Randomization using imaging and molecular biomarkers in I-SPY 2 non-responders$160,010
P01 · FY2019 · CA · contact PI
Breast Cancer Research Program$76,195
P30 · FY2019 · CA · contact PI
Breast Cancer Research Program$7,212
P30 · FY2019 · CA · contact PI
Breast Cancer Research Program$5,768
P30 · FY2019 · CA · contact PI
Breast Cancer Research Program$3,627
P30 · FY2019 · CA · contact PI
Breast Cancer Research Program$1,106
P30 · FY2019 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$660,057
R01 · FY2018 · CA
Project 01 - Sequential Multiple Assignment Randomization using imaging and molecular biomarkers in I-SPY 2 non-responders$179,826
P01 · FY2018 · CA · contact PI
Breast Cancer Research Program$155,631
P30 · FY2018 · CA · contact PI
Breast Cancer Research Program$9,404
P30 · FY2018 · CA · contact PI
Breast Cancer Research Program$2,510
P30 · FY2018 · CA · contact PI
Breast Cancer Research Program$2,143
P30 · FY2018 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$668,058
R01 · FY2017 · CA
Project 01 - Sequential Multiple Assignment Randomization using imaging and molecular biomarkers in I-SPY 2 non-responders$206,189
P01 · FY2017 · CA · contact PI
Breast Cancer Research Program$73,099
P30 · FY2017 · CA · contact PI
Breast Cancer Research Program$72,887
P30 · FY2016 · CA · contact PI
Molecular & Genetic Determinants of Outcome in Breast Cancer$296,181
R01 · FY2008 · CA · contact PI
Molecular & Genetic Determinants of Outcome in Breast Cancer$296,417
R01 · FY2007 · CA · contact PI
Molecular & Genetic Determinants of Outcome in Breast Ca$305,509
R01 · FY2006 · CA · contact PI
Molecular &Genetic Determinants of Outcome in Breast Ca$320,084
R01 · FY2005 · CA
Molecular &Genetic Determinants of Outcome in Breast Ca$213,975
R01 · FY2004 · CA
AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES$61,257
K23 · FY2004 · CA
AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES$123,080
K23 · FY2003 · CA
AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES$61,257
K23 · FY2002 · CA
AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES$128,799
K23 · FY2001 · CA
AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES$130,259
K23 · FY2000 · CA